논문상세정보
' Original Article : Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • 15-hydroxyprostaglandindehydrogenase
  • hepatocellular carcinoma
  • immunohistochemistry
  • survival analysis
  • transfection
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8,096 0

0.0%

' Original Article : Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma' 의 참고문헌

  • Sorafenib in advanced hepatocellular carcinoma
    Llovet JM N Engl J Med 359 : 378 ~ 390 - [2008]
  • Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression
    Mann JR Cancer Res 66 : 6649 ~ 6656 - [2006]
  • Regulation of COX-2 expression in human cancers
    Dixon DA. Prog Exp Tumor Res 37 : 52 ~ 71 - [2003]
  • Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma
    Castro-Sanchez L Int J Biochem Cell Biol 45 : 2501 ~ 2511 - [2013]
  • Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs)
    Tai HH Prostaglandins Other Lipid Mediat 96 : 37 ~ 40 - [2011]
  • Molecular targeted therapies in hepatocellular carcinoma
    Llovet JM Hepatology 48 : 1312 ~ 1327 - [2008]
  • Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic tumors
    Pham H Pancreas 39 : 332 ~ 339 - [2010]
  • Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages
    Diaz-Munoz MD Biochem J 443 : 451 ~ 461 - [2012]
  • Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer
    Yang L Cancer Res 67 : 5587 ~ 5593 - [2007]
  • Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs
    Wolfe MM N Engl J Med 340 : 1888 ~ 1899 - [1999]
  • Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation
    Koga H Hepatology 29 : 688 ~ 696 - [1999]
  • Cyclooxygenases 1 and 2
    Vane JR Annu Rev Pharmacol Toxicol 38 : 97 ~ 120 - [1998]
  • Cyclooxygenase-2 unlike cyclooxygenase-1 is highly expressed in ovine embryos during the implantation period
    Charpigny G Biol Reprod 57 : 1032 ~ 1040 - [1997]
  • Cyclooxygenase-2 expression in hepatocellular carcinoma
    Shiota G Hepatogastroenterology 46 : 407 ~ 412 - [1999]
  • Cyclooxygenase regulates angiogenesis induced by colon cancer cells
    Tsujii M Cell 93 : 705 ~ 716 - [1998]
  • Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition
    Simmons DL Pharmacol Rev 56 : 387 ~ 437 - [2004]
  • Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy
    Casado M FASEB J 15 : 2016 ~ 2018 - [2001]
  • Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
    Gupta RA Nat Rev Cancer 1 : 11 ~ 21 - [2001]
  • Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
    Bresalier RS N Engl J Med 352 : 1092 ~ 1102 - [2005]
  • Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells
    Abiru S Hepatology 35 : 1117 ~ 1124 - [2002]
  • 15-hydroxyprostaglandin dehydrogenase is downregulated and exhibits tumor suppressor activity in gastric cancer
    Song HJ Cancer Invest 29 : 257 ~ 265 - [2011]
  • 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer
    Thiel A Clin Cancer Res 15 : 4572 ~ 4580 - [2009]
  • 15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer
    Tai HH Prostaglandins Other Lipid Mediat 83 : 203 ~ 208 - [2007]
  • 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer
    Backlund MG J Biol Chem 280 : 3217 ~ 3223 - [2005]
  • 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy
    Na HK Biochem Pharmacol 82 : 1352 ~ 1360 - [2011]